NSCLC Connect
  • Saved

65-Year-Old Man with Rare Presentation of Lung Cancer

A 65-year-old male with a 40 pack-year smoking history presents with a dry cough that is sometimes accompanied by blood in the phlegm. His medical history is unremarkable.

His physical exam detected a rough respiratory murmur from each lung. Lab results were normal, except for an elevated...

  • Saved

Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer - PubMed

Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33908819/

doi: 10.1080/01902148.2021.1885525. Online ahead of print. 1 Department of Surgery, Thoracic Oncology Program, University of California, San Francisco, San Francisco, California, USA. Purpose: Non-small lung (NSCLC) is the deadliest cancer,...

  • Saved

Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations - PubMed

Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33866796/

Aim: To estimate real-world (rw) outcomes for first-line therapy in patients with advanced EGF receptor ( EGFR)-mutated non-small-cell lung cancer (NSCLC), focusing on specific mutation types. Patients & methods: Retrospective...

  • Saved

RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis - PubMed

RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33905962/

doi: 10.1016/j.ctarc.2021.100378. Online ahead of print. 1 Hospital doce de Octubre, Medical Oncology Department Thoracic Cancer and Early Drug Development Unit, Madrid, Spain. Electronic address: [email protected]. 2 Department of Oncology,...

  • Saved

  • 5yr
    What are your perceptions of patient access to biomarker testing? Please share.